IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases: Regulation of T helper 1/T helper 2 responses

British Journal of Pharmacology

Volumn 127, Issue 6, 1999, Pages 1295-1304

  Haskó, György ^a   Szabó, Csaba ^a  

^a INOTEK CORPORATION   (United States)

Author keywords

Autoimmune disease; Catecholamine; Cytokines; Inflammation; Interferon ; Interleukin 10; Interleukin 2; Interleukin 4; Nitric oxide; Transcription factors

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE; CALCITONIN GENE RELATED PEPTIDE; CAPTOPRIL; CLOBETASOL; CYCLIC AMP; CYTOKINE ANTIBODY; DEXAMETHASONE; GLIBENCLAMIDE; GLUCOCORTICOID; HYDROCORTISONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; LISINOPRIL; N(G) METHYLARGININE; NITRIC OXIDE; PROSTAGLANDIN E2; PROTEIN P40; SALBUTAMOL;

AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; DRUG TARGETING; HELPER CELL; HOST RESISTANCE; HUMAN; IMMUNOMODULATION; IMMUNOPATHOLOGY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; INFLAMMATION; INTERLEUKIN-12; TH1 CELLS; TH2 CELLS;

EID: 0032773289     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702689     Document Type: Review

References (129)

1. Ayyavoo, V., Mahboubi, A., Mahalingam, S., Ramalingam, R., Kudchodkar, S., Williams, W.V., Green, D.R. & Weiner, D.B. (1997). HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B. Nat. Med., 3, 1117-1123.
2. Bacon, C.M., McVicar, D.W., Ortaldo, J.R., Rees, R.C., O'Shea, J.J. & Johnston, J.A. (1995). Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12. J. Exp. Med., 181, 399-404.
3. Baron, P., Constantin, G., D'Andrea, A., Ponzin, D., Scarpini, E., Scarlato, G., Trinchieri, G., Rossi, F. &Cassatella, M.A. (1993). Production of tumor necrosis factor and other proinflammatory cytokines by human mononuclear phagocytes stimulated with myelin P2 protein. Proc. Natl. Acad. Sci. U.S.A., 90, 4414-4418.
4. Berg, D.J., Kühn, R., Rajewsky, K., Müller, W., Menon, S., Davidson, N., Grünig, G. & Rennick, D. (1995). Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J. Clin. Invest., 96, 2339-2347.
5. Biron, C.A. (1997). Activation and function of natural killer cell responses during viral infections. Curr. Opin. Immunol., 9, 24-34.
6. + lymphocytes. J. Immunol., 158, 5589-5595.
7. Braun, M.C., He, J., Wu, C.Y. & Kelsall, B.L. (1999). Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression. J. Exp. Med., 189, 541-552.
8. Bright, J.J., Du, C., Coon, M., Sriram, S. & Klaus, S.J. (1998). Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline. J. Immunol., 161, 7015-7022.
9. Bussolati, B., Mariano, F., Biancone, L., Foa, R., David, S., Cambi, V. & Camussi, G. (1999). Interleukin-12 is synthesized by mesangial cells and stimulates platelet-activating factor synthesis, cytoskeletal reorganization, and cell shape change. Am. J. Pathol., 154, 623-632.
10. Cassatella, M.A., Meda, I., Gasperini, S., D'Andrea, A., Ma, X. & Trinchieri, G. (1995). Interleukin-12 production by human polymorphonuclear leukocytes, Eur. J. Immunol., 25, 1-5.
11. Casteels, K., Waer, M., Bouillon, R., Depovere, J., Valckx, D., Laureys, J. & Mathieu, C. (1998). 1,25-Dihydroxyvitamin D3 restores sensitivity to cyclophosphamide-induced apoptosis in non-obese diabetic (NOD) mice and protects against diabetes, Clin. Exp. Immunol., 112, 181-187.
12. Chua, A.O., Chizzonite, R., Desai, B.B., Truitt, T.P., Nunes, P., Minetti, L.J., Warrier, R.R., Presky, D.H., Levine, J.F., Gately, M.K. & Gubler, U. (1994), Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130. J. Immunol., 153, 128-136.
13. Constantinescu, C.S., Goodman, D.B. & Ventura, E.S. (1998), Captopril and lisinopril suppress production of interleukin-12 by human peripheral blood mononuclear cells. Immun, Lett., 62, 25-31.
14. Cousens, L.P., Orange, J.S., Su, H.C. & Biron, C.A. (1997). Interferon-α/β inhibition of interleukine 12 and interferon-γ production in vitro and endogenously during viral infection. Proc. Natl. Acad. Sci. U.S.A., 94, 634-639.
15. 3: involvement of NF-κB downregulation in transcriptional repression of the p40 gene. J. Clin. Invest., 101, 252-262.
16. D'Andrea, A., Aste-Amezaga, M., Valiante, N.M., Ma, X., Kubin, M. & Trinchieri, G. (1993). Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells, J. Exp. Med., 178, 1041-1048.
17. D'Andrea, A., Ma, X., Aste-Amexaga, M., Paganin, C. & Trinchieri, G. (1995). Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor α production. J. Exp. Med., 181, 537-546.
18. D'Andrea, A., Rengaraju, M., Valiante, N.M., Chehimi, J., Kubin, M., Aste, M., Chan, S.H., Kobayashi, M., Young, D., Nickbarg, E., Chizzonite, R., Wolf, S.F. & Trinchieri, G. (1992). Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med., 176, 1387-1398.
19. + lymphocytes by inhibiting IL-12 production. J. Immunol., 160, 2231-2237.
20. Del Prete, G. (1998). The concept of type-1 and type-2 helper T cells and their cytokines in humans. Int. Rev. Immunol., 16, 427-455.
21. Dewit, D., Gourlet, P., Amraoui, Z., Vertongen, P., Willems, F., Robberecht, P. & Goldman, M. (1998). The vasoactive intestinal peptide analogue RO25-1553 inhibits the production of TNF and IL-12 by LPS-activated monocytes. Immunol. Lett., 60, 57-60.
22. Dumont, A., Hehner, S.P., Schmitz, M.L. Gustafsson, J.A., Liden, J., Okret, S., Van Der Saag, P.T., Wissink, S., Van Der Burg, B., Herrlich, P., Haegeman, G., De Bosscher, K, & Fiers, W. (1998). Cross-talk between steroids and NF-kappa B: what language? Trends Biochem. Sci., 23, 233-235.
23. Elenkov, I.J., Papanicolau, D.A., Wilder, R.L. & Chrousos, G.P. (1996). Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc. Assoc. Am. Physicians, 108, 1-8.
24. Elliott, M.J., Maini, R.N., Feldmann, M., Kalden, J.R., Antoni, C., Smolen, J.S., Leeb, B., Breedveld, F.C. Mac-Farlane, J.D., Bul, H. & Woody, J.N. (1994). Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet, 344, 1105-1110.
25. Flesch, I.E.A., Hess, J.H., Huang, S., Aguet, M., Rothe, J., Bluethmann, H. & Kaufmann, S.H.E. (1995). Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon 7 and tumor necrosis factor α. J. Exp. Med., 181, 1615-1621.
26. Fox, F.E., Kubin, M., Cassin, M., Niu, Z., Hosoi, J., Torii, H., Granstein, R.D., Trinchieri, G. & Rook, A.H. (1997). Calcitonin gene-related peptide inhibits proliferation and antigen presentation by human peripheral blood mononuclear cells: effects on B7, interleukin 10, and interleukin 12. J. Invest. Dermatol., 108, 43-48.
27. Gantner, F., Kupferschmidt, R., Schudt, C., Wendel, A. & Hatzelmann, A. (1997). In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumor necrosis factor-α release by PDE inhibitors. Br. J. Pharmacol., 121, 221-231.
28. Gately, M.K. (1997). Interleukin-12: potential clinical applications in the treatment of chronic viral hepatitis. J. Viral. Hepat., Suppl. 1, 33-39.
29. Gately, M.K., Renzetti, L.M., Magram, J., Stern, A.S., Adorini, L., Gubler, U & Presky, D.H. (1998). The interleukin-12 interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol., 16, 495-521.
30. Gavett, S.H., O'Hearn, D.J., Li, X., Huang, S.K., Finkelman, F.D. & Wills-Karp, M. (1995). Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med., 182, 1527-1536.
31. Gazzinelli, R.T., Hieny, S., Wynn, T.A., Wolf, S. & Sher, A. (1993). Interleukin 12 is required for the T-lymphocyte-independent induction of interferon γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. U.S.A., 90, 6115-6119.
32. Genain, C.P., Roberts, T., Davis, R.L., Nguyen, M.H., Uccelli, A., Faulds, D., Li, Y., Hedgpeth, J. & Hauser, S.L. (1995). Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor. Proc. Natl. Acad. Sci. U.S.A., 92, 3601-3605.
33. Germann, T , Szeliga, J., Hess, H., Storkel, J., Podlaski, P.J., Gately, M.K., Schmitt, E. & Rüde, E. (1995). Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA 1 mice. Proc. Natl. Acad. Sci. U.S.A., 92, 4823-4827.
34. Gerosa, F., Tommasi, M., Benati, C., Gandini, G., Libonati, M., Tridente, G., Carra, G. & Trinchieri, G. (1993). Differential effects of tyrosine kinase inhibition in CD69 antigen expression and lytic activity induced by rIL-2, rIL-12, and rIFN-α in human NK cells. Cell. Immunol., 150, 382-390.
35. Gillessen, S., Carvajal, D., Ling, P., Podlaski, F.J., Stremlo, D.L., Familletti, P.C., Gubler, U., Presky, D.H., Stern, A.S. & Gately, M.K. (1995). Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur. J. Immunol., 25, 200-206.
36. Gollob, J.A., Kawasaki, H. & Ritz, J. (1997). Interferon-γ and interleukin-4 regulate T cell interleukin-12 responsiveness through the differential modulation of high-affinity interleukin-12 receptor expression. Eur. J. Immunol., 27, 647-652.
37. Hamon, Y., Luciant, M.-F., Becq, F., Verrier, B., Rubartelli, A. & Chimini, G. (1997). Interleukin-1β secretion is impaired by inhibitors of the Atp binding cassette transporter, ABCL Blood, 90, 2911-2915.
38. 3 adenosine receptors decreases IL-12, IFN-γ, and nitric oxide production and prevents lethality in endotoxemic mice. Eur. J. Pharmacol., 358, 261-268.
39. Haskó, G., Shanley, T.P., Egnaczyk, G., Nemeth, Z.H., Salzman, A.L., Vizi, E.S. & Szabó, C. (1998b). Exogenous and endogenous catecholamines inhibit the production of macrophage inflammatory protein (MIP) 1α via a β adrenoceptor mediated mechanism. Br. J Pharmacol., 125, 1297-1304.
40. Haskó, G. & Szabó, C. (1998). Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system, Biochem. Pharmacol., 56, 1079-1087.
41. Haskó, G., Szabó, C., Németh, Z.H., Lendval, B. & Vizi, E.S. (1998c). Modulation by dantrolene of endotoxin-induccd interleukin-10, tumor necrosis factor-α, and nitric oxide production in vivo and in vitro. Br. J. Pharmacol., 124, 1099-1106.
42. Haskó, G., Szabó, C., Nemeth, Z.H., Salzman, A.I., & Vizi, E.S. (1998d). Stimulation of β-adrenoceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient mice. J. Neuroimmunol., 88, 57-61.
43. Haskó, G., Szabó, C., Nemeth, Z.H., Salzman, A.L. & Vizi, E.S. (1998e). Suppression of interleukin-12 production by phosphodiesterase inhibition in murine endotoxemia is interleukin-10 independent. Eur. J. Immunol. 28, 468-472.
44. Haskó, G , Viråg, L., Egnaczyk, G., Salman, A.L. & Szahó, C. (1998f). The crucial role of IL-10 in the suppression of the immunological response in mice exposed to staphylococcal enterotoxin B. Eur. J. Immunol., 28, 1417-1425.
45. Haslberger, A., Romanin, C. & Koerber, R. (1992). Membrane potential modulates release of tumor necrosis factor in lipopolysaccharide-stimulated mouse macrophages. Mol. Biol. Cell., 3, 451-460.
46. Hayes, M.P., Wang, J. & Norcross, M.A. (1995). Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-γ of lipopolysaccharide-inducible p35 and p40 genes. Blood, 86, 646-650.
47. Heinzel, F.P., Hujer, A.M., Ahmed, F.N. & Rerko, R.M. (1997). In vivo production and function of IL-12 p40 homodimers. J. Immunol., 158, 4381-4388.
48. + T cells resulting in a state of unresponsiveness to IL-12. J. Immunol., 161, 6156-6163.
49. 3 adenosine receptor ablation on mouse mast cell function. FASEB J., 13, A324.
50. Hogaboam, C.M., Chensue, S.W., Steinhauser, M.L., Huffnagle, G.B., Lukacs, N.W., Strieter, R.M. & Kunkel, S.L. (1997). Alteration of the cytokine phenotype in an experimental lung granuloma model by inhibiting nitric oxide. J. Immunol., 159, 5585-5593.
51. Hogaboam, C.M., Gallinat, C.S., Bone-Larson, C., Chensue, S.W., Lukacs, N.W., Strieter, R.M. & Kunkel, S.L. (1998). Collagen deposition in a non-fibrotic lung granuloma model after nitric oxide inhibition. Am. J. Pathol., 153, 1861-1872.
52. Homey, B., Assmann, T., Vohr, H.W., Ulrich, P., Lauerma, A.L., Ruzicka, T., Lehmann, P. & Schuppe, H.C. (1998). Topical FK506 suppresses cytokine and costimulatory molecule expression in epidermal and local draining lymph node cells during primary skin immune responses. J. Immunol., 160, 5331-5340.
53. + T cells through IL-12 produced by Listeria-induced macrophages. Science, 260, 547-549.
54. Huang, F.P., Niedbala, W., Wei, X.Q., Xu, D., Feng, G.J., Robinson, J.H., Lam, C. & Liew, F.Y. (1998). Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. Eur. J. Immunol., 28, 4062-4070.
55. Jacobsen, S.E. (1995). ILI2, a direct stimulator and indirect inhibitor of haematopoiesis. Res. Immunol., 146, 506-514.
56. Jacobson, N.G., Szabo, S.J., Weber-Nordt, R.M., Zhong, Z., Schreiber, R.D., Darnell, JR. J.E. & Murphy, K.M. (1995). Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J. Exp. Med., 181, 1755-1762.
57. Kang, K., Kubin, M., Cooper, K.D., Lessin, S.R., Trinchieri, G. & Rook, A.H. (1996). IL-12 synthesis by human Langerhans cells. J. Immunol., 156, 1402-1407.
58. Kelly, J.J., Barnes, P.J. & Giembycz., M.A. (1998). Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors. Br. J. Pharmacol., 124, 129-140.
59. Kitching, A.R., Tipping, P.G. & Holdsworth, S.R. (1999). IL-12 directs severe renal injury, crescent formation and Th1 responses in murine glomerulonephritis. Eur. J. Immunol., 29, 1-10.
60. Klinman, D.M., YI, A.K., Beaucage, S.L., Conover, J. & Krieg, A.M. (1996). CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ. Proc. Natl. Acad. Sci. U.S.A., 93, 2879-2883.
61. Kobayashi, M., Fitz, L., Ryan, M., Hewick, R.M., Clark, S.C., Chan, S., Loudon, R., Sherman, F., Perussia, B. & Trinchieri, G. (1989). Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med., 170, 827-845.
62. Leonard, J.P., Waldburger, K.E & Goldman, S.J. (1995). Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med., 181, 381-386.
63. 2 on microglial functions. Biochimie, 80, 899-904.
64. Liang, L., Beshay, F. & Prud'Homme, G.J. (1998). The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice. Diabetes, 47, 570-575.
65. Ling, P., Gately, M.K., Gubler, U., Stern, A.S., Lin, P., Hollfelder, K., Su, C., Pan, Y.C. & Hakimi, J. (1995). Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J. Immunol., 154, 116-127.
66. Lotze, M.T., Zitvogel, L., Campbell, R., Robbins, P.D., Elder, E., Haluszczak, C., Martin, D., Whiteside, T.L., Storkus, W.J. & Tahara, H. (1996). Cytokine gene therapy of cancer using interleukin-12: murine and clinical trials. Ann. N.Y. Acad. Sci., 795, 440-454.
67. Ma, X., Chow, J.M., Gri, G., Carra, G., Gerosa, F., Wolf, S.F., Dzialo, R. & Trinchieri, G. (1996). The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J. Exp. Med., 183, 147-157.
68. + T cells. J. Immunol., 154, 5071-5079.
69. MacLean, A., Wei, X.Q., Huang, F.P., Al-Alem, U.A., Chan, W.L. & Liew, F.Y. (1998). Mice lacking inducible nitric oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th1 cell responses. J. Gen. Virol., 79, 825-830.
70. Mattner, F., Ozmen, L., Podlaski, F.J., Wilkinson, V.L., Presky, D.H., Gately, M.K. & Alber, G. (1997). Treatment with homodimeric interleukin-12 (IL-12) p40 protects mice from IL-12-dependent shock but not from tumor necrosis factor α-dependent shock. Infect. Immun., 65, 4734-4737.
71. Mazzeo, D., Panina-Bordignon, P., Recalde, H., Siniga-Glia, F. & D'Ambrosio, D. (1998). Decreased IL-12 production and Th1 cell development by acetyl salicylic acid-mediated inhibition of NF-κB. Eur. J. Immunol., 28, 3205-3213.
72. 3 receptors on macrophages inhibits tumor necrosis factor-α Eur. J. Pharmacol., 310, 209-216.
73. Metzger, D.W., Vogel, L.A., Van Cleave, V.H., Lester, T.I.. & Buchanan, J.M. (1995). The effects of IL12 on B-cell subset function. Res. Immunol., 146, 499-505.
74. Moller, D.R., Wysocka, M., Greenlee, B.M., Ma, X., Wahl, L., Flockhart, D.A., Trinciheri, G. & Karp, C.I.. (1997). Inhibition of IL-12 production by thalidomide. J. Immunol., 159, 5157-5161.
75. Moreland, L.W., Baumgartner, S.W., Schiff, M.H., Tindall, E.A., Fleischmann, R.M., Weaver, A.L., Ettlinger, R.E., Cohen, S., Koopman, W.J., Mohler, K., Widmer, M.B. & Blosch, C.M. (1997). Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fe fusion protein. N. Engl. J. Med., 337, 141-147.
76. Muller, G., Saloga, J., Germann, T., Bellinghausen, L. Mohamadzadeh, M., Knop, J. & Enk, A.H. (1994). Identification and induction of human keratinocyte-derived IL-12. J. Clin. Invest., 94, 1799-1805.
77. Murphy, T.L., Cleveland, M.G., Kulesza, P., Magram, J. & Murphy, K.M. (1995). Regulation of interleukin 12 p40 expression through an NF-κB half-site. Mol. Cell. Biol., 15, 5258-5267.
78. Na, S.-Y., Kang, B.Y., Chung, S.W., Han, S.-J., Ma, X., Trinchieri, G., Im, S.-Y., Lee, J.W. & Kim, T.S. (1999). Retinoids inhibit interleukin-12 production in macrophages through physical association of retinoid X receptor and NFκB. J. Biol, Chem., 274, 7674-7680.
79. Németh, Z.H., Haskó, G., Szabó, C., Salzman, A.L. & Vizi, F.S. (1998b). Calcium channel blockers and dantrolene differentially regulate the production of interleukin-12 and interferon-γ in endotoxemic mice. Brain Res. Bull., 46, 257-261.
80. Németh, Z.H., Haskó, G. & Vizi, E.S. (1998a). Pyrrolidine dithiocarbamate augments IL-10, inhibits TNF-α, MIP-Iα, IL-12, and nitric oxide production and protects from the lethal effect of endotoxin. Shock, 10, 49-53.
81. Neurath, M.F., Fuss, I., Kelsall, B.L., Stuber, E. & Strober, W. (1995). Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med., 182, 1281-1290.
82. Ozmen, J., Pericin, M., Hakimi, J., Chizzonite, R.A., Wysocka, M., Trinchieri, G., Gately, M. & Garotta, G. (1994). Interleukin 12, interferon gamma, and tumor necrosis factor α are the key cytokines of the generalized Shwartzman reaction. J. Exp. Med., 180, 907-915.
83. 2-agonists prevent TH1 development by selective inhibition of interleukin 12. J. Clin. Invest., 100, 1513-1519.
84. Park, J.H. & Shin, S.H. (1996). Induction of IL-12 gene expression in the brain in septic shock. Biochem. Biophys. Res. Commun., 224, 391-396.
85. Pastores, S.M., Haskó G., Vizi, E.S. & Kvetan, V. (1996). The role of vasoactive drugs in the regulation of cytokine production in sepsis. New Horiz., 4, 252-264.
86. Petrovsky, N., McNair, P. & Harrison, L.C. (1998). Diurnal rhythms of pro-inflammatory cytokines; regulation by plasma cortisol and therapeutic implications. Cytokine, 10, 307-312.
87. Plevy, S.E., Gemberling, J.H., Hsu, S., Dorner, A.J. & Smale, S.T. (1997). Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins. Mol. Cell. Biol., 17, 4572-4588.
88. Poggi, A., Rubartelli, A. & Zocchi, M.R. (1998). Involvement of dihydropyridine-sensitive calcium channels in human dendritic cell function. Competition by HIV-1 Tat. J. Biol. Chem., 273, 7205-7209.
89. Presky, D.H., Yang, H., Minetti. L.J., Chua, A.O., Nabavi, N., Wu, C.Y., Gately, M.K. & Gubler, U. (1996). A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits. Proc. Natl. Acad. Sci. U.S.A., 93, 14002-14007.
90. Ralevic, V. & Burnstock, G. (1998). Receptors for purines and pyrimidines. Pharmacol. Rev., 50, 413-492.
91. Randow, F., Döcke, W.-D., Bundschuh, D.S., Hartung, T., Wendel, A. & Volk, H.-D. (1997). In vitro prevention and reversal of lipopolysaccharide desensitization by INF-γ, IL-12, and granulocyte-macrophage colony-stimulating factor. J. Immunol., 158, 2911-2918.
92. Redford, T.W., Yi, A.-K., Ward, C.T. & Krieg, A.M. (1998). Cyclosporin A enhances IL-12 production by CpG motifs in bacterial DNA and synthetic oligodeoxynucleotides. J. Immunol., 161, 3930-3935.
93. + T cells during initiation of infection. J. Exp. Med., 179, 447-456.
94. Rieckmann, P., Weber, F., Günther, A., Martin, S., Bitsch, A., Broocks, A., Kitze, B., Weber, T., Börner, T. & Poser, S. (1996). Pentoxyfilline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis. J. Neuroimmunol., 64, 193-200.
95. Rogge, L., Barberis-Maino, L., Biffi, M., Passini, N., Presky, D.H., Gubler, U. & Sinigaglia, F. (1997). Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med., 185, 825-831.
96. Ross, S.E., Williams, R.O., Mason, L.J., Mauri, C., Marinova-Mutafchieva, L., Malfait, A.M., Maini, R.N. & Feldmann, M. (1997). Suppression of TNF-α expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram. J. Immunol., 159, 6253-6259.
97. Rothe, H., Hartmann, B., Geerlings, P. & kolb, H. (1996). Interleukin-12 gene-expression of macrophages is regulated by nitric oxide. Biochem. Biophys. Res. Commun., 224, 159-163.
98. 2. Diabetologia, 40, 641-646.
99. 3 adenosine receptors. J. Immunol., 156, 3435-3442.
100. Shu, U., Kiniwa, M., Wu, C.Y., Maliszewski, C., Vezzio, N., Hakimi, J., Gately, M. & Delespesse, G. (1995). Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol., 25, 1125-1128.
101. Smith, T.J., Ducharme, L.A. & Weis, J.H. (1994). Preferential expression of interleukin-12 or interleukin-4 by murine bone marrow mast cells derived in mast cell growth factor or interleukin-3. Eur. J. Immunol., 24, 822-826.
102. Snijders, A., Hilkens, C.M.U., Van Der Pouw Kraan, T.C.T.M., Engel, M., Aarden, L.A. & Kapsenberg, M.L. (1996). Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit. J. Immunol., 156, 1207-1212.
103. Sommer, N., Löschmann, P.-A., Northoff, G.H., Weller, M., Steinbrecher, A., Steinbach, J.P., Lichtenfels, R., Meyermann, R., Riethmüller, A., Fontana, A., Dichgans, J. & Martin, R. (1995). The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nat. Medicine, 1, 244-248.
104. Souness, J.E., Griffin, M., Maslen, C., Ebsworth, K., Scott, L.C., Pollock, K., Palfreyman, M.N. & Karlsson, J.A. (1996). Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF-α generation from human monocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformer. Br. J. Pharmacol., 118, 649-658.
105. Sousa, C.R., Hieny, S., Scharton-Kersten, T., Jankovic, D., Charest, H., Germain, R.N. & Sher, A. (1997). In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med., 186, 1819-1829.
106. Stalder, A.K., Pagenstecher, A., Yu, N.C., Kincaid, C., Chiang, C.S., Hobbs, M.V., Bloom, F.E. & Campbell, I.L. (1997). Lipopolysaccharide-induced IL-12 expression in the central nervous system and cultured astrocytes and microglia. J. Immunol., 159, 1344-1351.
107. Szabó, C., Haskó, G., Németh, Z.H. & Vizi, E.S. (1997a). Calcium entry blockers increase interleukin-10 production in endotoxemia. Shock, 7, 304-307.
108. Szabó, C., Scott, G.S., Viråg, L., Egnaczyk, G., Salzman, A.L., Shanley, T.P. & Haskó, G. (1998). Suppression of macrophage inflammatory protein (MIP)-1 α production and collagen-induced arthritis by adenosine receptor agonists. Br. J. Pharmacol., 125, 379-387.
109. Szabo, S.J., Dighe, A.S., Gubler, U. & Murphy, K.M. (1997b). Regulation of the interleukin (IL)-12R β2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med., 185, 817-824b.
110. Takahashi, M., Ogasawara, K., Takeda, K., Hashimoto, W., Sakihara, H., Kumagai, K., Anzai, R., Satoh, M. & Seki, S. (1996). LPS induces NKL1 alpha beta T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells. J. Immunol., 156, 2436-2442.
111. 2 protects against liver injury after Escherichia coli infection but hampers the resolution of the infection in mice. J. Immunol., 161, 3019-3025.
112. Taoufik, Y., Lantz, O., Wallon, C., Charles, A., Dussaix, E. & Delfraissy, J.F. (1997). Human immunodeficiency virus gp120 inhibits interleukin-12 secretion by human monocytes: an indirect interleukin-10-mediated effect. Blood. 89, 2842-2848.
113. Trembleau, S., Penna, G., Bosi, E., Mortara, A., Gately, M.K. & Adorini, L. (1995). Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med., 181, 817-821.
114. Trepicchio, W.L., Bozza, M., Pedneault, G. & Dorner, A.J. (1996). Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. J. Immunol., 157, 3627-3634.
115. Trinchieri, G. (1995). Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol., 13, 251-276.
116. Tripp, C.S., Wolf, S.F. & Unanue, E.R. (1993). Interleukin 12 and tumor necrosis factor α are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. U.S.A., 90, 3725-3729.
117. Uyemura, K., Demer, L.L., Castle, S.C., Jullien, D., Berliner, J.A., Gately, M.K., Warrier, R.R., Pham, N., Fogelman, A.M. & Modlin, R.L. (1996). Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J. Clin. Invest., 97, 2130-2138.
118. Van Der Pouw Kraan, T.C.T.M., Boeije, L.C.M., Smeenk, R.J.T., Wijdenes, J. & Aarden, L.A. (1995). Prostaglandin-E2 is a potent inhibitor of human interleukin-12 production. J. Exp. Med., 181, 775-779.
119. 2 receptors. J. Clin. Invest., 102, 1866-1873.
120. Verghese, M.W., McConnell, R.T., Strickland, A.B., Gooding, R.C., Stimpson, S.A., Yarnall, D.P., Taylo, J.D. & Furdon, P.J. (1995). Differential regulation of human monocyte-derived TNF-α and IL-1β by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors. J. Pharmacol. Exp. Ther., 272, 1313-1320.
121. Vieira, P.L., Kalinski, P., Wierenga, E.A., Kapsenberg, M.L., & De Jong, E.C. (1998). Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential. J. Immunol., 161, 5245-5251.
122. Wilckens, T. & De Rijk, R. (1997). Glucocorticoids and immune function: unknown dimensions and new frontiers. Immunol. Today, 18, 418-424.
123. 2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. J. Immunol., 161, 2723-2730.
124. Wu, C., Warrier, R.R., Wang, X., Presky, D.H. & Gately, M.K. (1997). Regulation of interleukin-12 receptor β1 chain expression and interleukin-12 binding by human peripheral blood mononuclear cells. Eur. J. Immunol., 27, 147-154.
125. Wysocka, M., Kubin, M., Vieira, L.Q., Ozmen, L., Garrotta, G., Scott, P. & Trinchieri, G. (1995). Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol., 25, 672-676.
126. Xin, Z., & Sriram, S. (1998). Vasoactive intestinal peptide inhibits IL-12 and nitric oxide production in murine macrophages. J. Neuroimmunol., 89, 206-212.
127. Yawalkar, N., Karlen, S., Hunger, R., Brand, C.U. & Braathen, L.R. (1998). Expression of interleukin-12 is increased in psoriatic skin. J. Invest. Dermatol., 111, 1053-1057.
128. Ye, J., Ortaldo, J.R., Conlon, K., Winkler-Pickett, R. & Young, H.A. (1995). Cellular and molecular mechanisms of IFN-γ production induced by IL-2 and IL-12 in a human NK cell line. J. Leuk. Biol., 58, 225-233.
129. Zhang, M., Gately, M.K., Wang, E., Gong, J., Wolf, S.F., Lu, S., Modlin, R.L. & Barnes, P.F. (1994). Interleukin 12 at the site of disease in tuberculosis. J. Clin. Invest., 93, 1733-1739.